Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Pneumococcal

View all HPV Plague Tetanus
Anthrax Influenza Pneumococcal Typhoid
Diphtheria Japanese encephalitis Polio Varicella (chickenpox)
General Recommendations Measles Rabies Yellow fever
Hib Meningococcal Rotavirus Zoster (shingles)
Hepatitis A Mumps Rubella  
Hepatitis B Pertussis Smallpox  
 

Recommendations - Pneumococcal

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 4, 2015; 64(34):944-947
HTML  |  PDF
 
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 19, 2014; 63(37):822-825
HTML  |  PDF
 
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
 
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, October 12, 2012; 61(40):816-9
HTML  |  PDF
 
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5
HTML  |  PDF
 
Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
Source: MMWR, December 10, 2010; 59(RR11):1-18
HTML  |  PDF
 
Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6
HTML  |  PDF
 
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):258-261
HTML  |  PDF
 
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344
HTML  |  PDF
 
Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients
Source: MMWR, Early Release, July 31, 2003, Vol. 52;1-2
HTML  |  PDF
 
Preventing Pneumococcal Disease Among Infants and Young Children
Source: MMWR October 6, 2000 / Vol. 49 / No. RR-09
HTML  |  PDF
 
Prevention of Pneumococcal Disease
Source: MMWR April 04, 1997 / Vol. 46 / No. RR-08
HTML  |  PDF
This page was updated on July 16, 2016.
This page was reviewed on July 16, 2016.
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000589) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.